Blood Loss, Postoperative clinical trials at University of California Health
2 in progress, 1 open to eligible people
Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)
open to eligible people ages 18 years and up
Prospective, multi-center, double-blind, randomized pivotal trial to evaluate the safety and effectiveness of the DrugSorb-ATR system for intraoperative removal of ticagrelor in patients undergoing urgent cardiothoracic (CT) surgery with cardiopulmonary bypass (CPB).
at UC Davis
Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)
Sorry, in progress, not accepting new patients
Prospective, Multicenter, Double-blind, Randomized, Study to Evaluate DrugSorb-ATR Removal of Apixaban and Rivaroxaban to Reduce Likelihood of Serious Bleeding in Patients Undergoing Urgent Cardiothoracic Surgery
at UC Davis
Our lead scientists for Blood Loss, Postoperative research studies include Sabrina Evans, MD.
Last updated: